168 related articles for article (PubMed ID: 9542584)
1. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle.
Gossrau R
Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase (NOS) I during postnatal development in rat and mouse skeletal muscle.
Christova T; Grozdanovic Z; Gossrau R
Acta Histochem; 1997 Aug; 99(3):311-24. PubMed ID: 9381914
[TBL] [Abstract][Full Text] [Related]
3. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle.
Grozdanovic Z; Gossrau R
Cell Tissue Res; 1998 Jan; 291(1):57-63. PubMed ID: 9394043
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase I (NOS-I) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin.
Grozdanovic Z; Gosztonyi G; Gossrau R
Acta Histochem; 1996 Jan; 98(1):61-9. PubMed ID: 9054190
[TBL] [Abstract][Full Text] [Related]
5. Differences in the localization of the postsynaptic nitric oxide synthase I and acetylcholinesterase suggest a heterogeneity of neuromuscular junctions in rat and mouse skeletal muscles.
Grozdanovic Z; Christova T; Gossrau R
Acta Histochem; 1997 Mar; 99(1):47-53. PubMed ID: 9150796
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase I (NOS I) is a costameric enzyme in rat skeletal muscle.
Gossrau R
Acta Histochem; 1998 Nov; 100(4):451-62. PubMed ID: 9842423
[TBL] [Abstract][Full Text] [Related]
7. Adhalin (alpha-sarcoglycan) is not required for anchoring of nitric oxide synthase I (NOS I) to the sarcolemma in non-mammalian skeletal (striated) muscle fibers.
Gossrau R; Christova T; Grozdanovic Z; Blottner D
Acta Histochem; 1996 Jul; 98(3):345-55. PubMed ID: 8863863
[TBL] [Abstract][Full Text] [Related]
8. NO synthase II in mouse skeletal muscle is associated with caveolin 3.
Gath I; Ebert J; Gödtel-Armbrust U; Ross R; Reske-Kunz AB; Förstermann U
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):723-8. PubMed ID: 10359657
[TBL] [Abstract][Full Text] [Related]
9. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-2 is present in the sarcolemma region of skeletal muscle fibers and is non-continuously co-localized with nitric oxide synthase-1.
Baum O; Feussner M; Richter H; Gossrau R
Acta Histochem; 2000 Aug; 102(3):281-98. PubMed ID: 10990066
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy.
Punkt K; Schering S; Löffler S; Minin EA; Samoilova VE; Hasselblatt M; Paulus W; Müller-Werdan U; Demus U; Koehler G; Boecker W; Buchwalow IB
Biochem Biophys Res Commun; 2006 Sep; 348(1):259-64. PubMed ID: 16876119
[TBL] [Abstract][Full Text] [Related]
12. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
Ségalat L; Grisoni K; Archer J; Vargas C; Bertrand A; Anderson JE
Exp Cell Res; 2005 Jan; 302(2):170-9. PubMed ID: 15561099
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
14. The specificity of the histochemical NADPH diaphorase reaction for nitric oxide synthase-1 in skeletal muscles is increased in the presence of urea.
Baum O; Miethke A; Wöckel A; Willerding G; Planitzer G
Acta Histochem; 2002; 104(1):3-14. PubMed ID: 11993849
[TBL] [Abstract][Full Text] [Related]
15. Association of neuronal nitric oxide synthase (nNOS) with alpha1-syntrophin at the sarcolemma.
Miyagoe-Suzuki Y; Takeda SI
Microsc Res Tech; 2001 Nov; 55(3):164-70. PubMed ID: 11747091
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest.
Rudnick J; Püttmann B; Tesch PA; Alkner B; Schoser BG; Salanova M; Kirsch K; Gunga HC; Schiffl G; Lück G; Blottner D
FASEB J; 2004 Aug; 18(11):1228-30. PubMed ID: 15180967
[TBL] [Abstract][Full Text] [Related]
17. Association of soluble guanylate cyclase with the sarcolemma of mammalian skeletal muscle fibers.
Feussner M; Richter H; Baum O; Gossrau R
Acta Histochem; 2001 Jul; 103(3):265-77. PubMed ID: 11482373
[TBL] [Abstract][Full Text] [Related]
18. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase-1 is enriched in fast-twitch oxidative myofibers.
Planitzer G; Miethke A; Baum O
Cell Tissue Res; 2001 Nov; 306(2):325-33. PubMed ID: 11702244
[TBL] [Abstract][Full Text] [Related]
20. Expression of Leu-19 (CD56, N-CAM) and nitric oxide synthase (NOS) I in denervated and reinnervated human skeletal muscle.
Gosztonyi G; Naschold U; Grozdanovic Z; Stoltenburg-Didinger G; Gossrau R
Microsc Res Tech; 2001 Nov; 55(3):187-97. PubMed ID: 11747094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
